Navigating the CMS 14-Day Rule in Biomarker TestingVideo Categories: PMO Interview with the Innovator Series: Volume 12 and Video Library
Drs. David Rimm and Roy Herbst review the problems with the CMS “14-Day Rule” since some of the multigene panel biomarker tests require 21 days or longer to complete.
Dr. Mesa describes why patients with PV who have a broad and heterogeneous course should seek a referral from a specialty center.Supported through funding from Incyte
Dr. Vij delves into the role of bioinformatics in identifying targets for drug development.